Skip to main content

AusPAR: Dasatinib

Australian Public Assessment Report
Device/Product Name
Sprycel
Active ingredients
Dasatinib
AusPAR Date
Published
Submission Number
PM-2016-04274-1-4
Submission Type
Major variation (new indication)
Decision
Approved

Help us improve the Therapeutic Goods Administration site